The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Companies / C••••••• B•• I•••

C••••••• B•• I•••

Stage unknownClaymont, DEc•••••••••.comBiotechnology
Facts
Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
$25.0Msum of rounds with a disclosed amount only
Named investors
5
Financing history
2 rounds
  1. Jan 13, 2026
    Funding round · $25.0M (disclosed)
    B••••••• V•••••• P••••••• (lead) via A••••• H••••T•• P••••••• (participant)V•••••• I••••••••• P••••••• (participant)S•••• C•••••• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “C••••••• B•• raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company”
  2. Sep 24, 2025
    Form D equity offering · $25.0M (form d sold) · 19 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “C••••••• B•• I••• filed Form D: $25,000,000 sold of $25,000,000, Biotechnology”
Investors on record
8 edges
People
3 officers, 2 directors
Timeline
3
  1. Sep 16, 2026
    C••••••• B•• I••• no longer listed on T•• P•••••••'s portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Apr 28, 2026
    C••••••• B•• I••• filed Form D: $25,000,000 sold of $25,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Jan 13, 2026
    C••••••• B•• announced Funding round of $25,000,000, led by B••••••• V•••••• P•••••••
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
19 observations
Every observation on this company